Leerink Partners Starts IDEXX Laboratories (IDXX) at Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mailGet Alerts IDXX Hot Sheet
Price: $560.38 --0%
Rating Summary:
13 Buy, 9 Hold, 3 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 7 | Down: 13 | New: 17
Rating Summary:
13 Buy, 9 Hold, 3 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 7 | Down: 13 | New: 17
Join SI Premium – FREE
Leerink Partners analyst Daniel Clark initiates coverage on IDEXX Laboratories (NASDAQ: IDXX) with a Outperform rating and a price target of $500.00.
For an analyst ratings summary and ratings history on IDEXX Laboratories click here. For more ratings news on IDEXX Laboratories click here.
Shares of IDEXX Laboratories closed at $421.75 yesterday.
You May Also Be Interested In
- Citizens Starts Oaktree Specialty Lending Corp (OCSL) at Market Perform
- Citi Resumes Prysmian SpA (PRY:IM) (PRYMY) at Buy
- Goldman Sachs Starts Accelevation Holdings (ACCV) at Buy
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
